|
|
||||||||
1 Department of Medicine, Duke University and Durham Veterans Affairs Medical Center, Durham 27710; and 2 Departments of Medicine and 3 Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina 27599-7545
The kidney plays a
central role in long-term regulation of arterial blood pressure and
salt and water homeostasis. This is achieved in part by the local
actions of paracrine and autacoid mediators such as the arachidonic
acid-prostanoid system. The present study tested the role of specific
PGE2 E-prostanoid (EP) receptors in the regulation of renal
hemodynamics and vascular reactivity to PGE2. Specifically,
we determined the extent to which the EP2 and
EP3 receptor subtypes mediate the actions of PGE2 on renal vascular tone. Renal blood flow (RBF) was
measured by ultrasonic flowmetry, whereas vasoactive agents were
injected directly into the renal artery of male mice. Studies were
performed on two independent mouse lines lacking either EP2
or EP3 (
/
) receptors and the results were compared with
wild-type controls (+/+). Our results do not support a unique role of
the EP2 receptor in regulating overall renal hemodynamics.
Baseline renal hemodynamics in EP2
/
mice [RBF
EP2
/
: 5.3 ± 0.8 ml · min
1 · 100 g kidney
wt
1; renal vascular resistance (RVR) 19.7 ± 3.6 mmHg · ml
1 · min · g kidney wt]
did not differ statistically from control mice (RBF +/+: 4.0 ± 0.5 ml · min
1 · 100 g kidney
wt
1; RVR +/+: 25.4 ± 4.9 mmHg · ml
1 · min · 100 g kidney
wt
1). This was also the case for the peak RBF increase
after local PGE2 (500 ng) injection into the renal artery
(EP2
/
: 116 ± 4 vs. +/+: 112 ± 2% baseline
RBF). In contrast, we found that the absence of EP3
receptors in EP3
/
mice caused a significant increase (43%) in basal RBF (7.9 ± 0.8 ml · min
1 · g kidney wt
1,
P < 0.05 vs. +/+) and a significant
decrease (41%) in resting RVR (11.6 ± 1.4 mmHg · ml
1 · min · g kidney
wt
1, P < 0.05 vs. +/+). Local
administration of 500 ng of PGE2 into the renal artery
caused more pronounced renal vasodilation in EP3
/
mice
(128 ± 2% of basal RBF, P < 0.05 vs.
+/+). We conclude that EP3 receptors mediate
vasoconstriction in the kidney of male mice and its actions are
tonically active in the basal state. Furthermore, EP3
receptors are capable of buffering PGE2-mediated renal vasodilation.
knockout mice; renal blood flow; EP receptor; cAMP; renal circulation; vascular smooth muscle cells
This article has been cited by other articles:
![]() |
H. Francois, C. Facemire, A. Kumar, L. Audoly, B. Koller, and T. Coffman Role of Microsomal Prostaglandin E Synthase 1 in the Kidney J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1466 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Opay, C. R. Mouton, J. J. Mullins, and K. D. Mitchell Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, September 1, 2006; 291(3): F612 - F618. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schweda, J. Klar, S. Narumiya, R. M. Nusing, and A. Kurtz Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys Am J Physiol Renal Physiol, September 1, 2004; 287(3): F427 - F433. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suganami, K. Mori, I. Tanaka, M. Mukoyama, A. Sugawara, H. Makino, S. Muro, K. Yahata, S. Ohuchida, T. Maruyama, et al. Role of Prostaglandin E Receptor EP1 Subtype in the Development of Renal Injury in Genetically Hypertensive Rats Hypertension, December 1, 2003; 42(6): 1183 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig, M. D. Breyer, and R. M. Breyer Contribution of prostaglandin EP2 receptors to renal microvascular reactivity in mice Am J Physiol Renal Physiol, September 1, 2002; 283(3): F415 - F422. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |